ISCT 2020 | Main areas of progress in stem cell therapies

Marc Peschanski, MD, PhD, of the Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem), Paris, France, outlines advances in stem cell therapies and clinical trials evaluating their use. Specifically discussed are pluripotent stem cells and their capacity to differentiate into retinal pigmented epithelial cells, and the potential advantages of their use. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).